Kisspeptin-10
KISS1 (112-121) / Metastin fragment
Kisspeptin-10 Research Protocol
Quickstart Overview
Kisspeptin-10 is the 10-amino-acid active fragment of kisspeptin, the master upstream regulator of the reproductive axis. It stimulates GnRH release, driving endogenous LH, FSH and downstream sex-hormone production, and is studied in fertility and hormonal research.
Scientific Data
Dosing & Reconstitution Guide
Units assume a U-100 insulin syringe (100 units = 1 mL). Acts upstream of GnRH; short half-life favours pulsatile dosing.
Reconstitution Steps
- 1Allow the lyophilized vial and bacteriostatic water to reach room temperature (~15 min).
- 2Swab both vial stoppers with a fresh 70% isopropyl alcohol pad and let them dry.
- 3Draw 2.0 mL of bacteriostatic water into a mixing syringe.
- 4Insert at an angle and let the water run slowly down the glass wall — never directly onto the powder.
- 5Gently swirl (do not shake) until the solution is completely clear.
- 6Label with date and concentration (mg/mL) and refrigerate at 2–8 °C immediately.
Supplies Needed
Planning example for a 6-week protocol at approximately 250 mcg per day.
Protocol Overview
Dosing Protocol
Storage Instructions
Important Notes
- Short half-life means frequent/pulsatile dosing.
- Continuous high dosing can desensitise the receptor.
How This Works
Kisspeptin neurons sit at the top of the reproductive (HPG) axis. Kisspeptin-10 binds the KISS1R (GPR54) receptor on GnRH neurons, triggering pulsatile GnRH release, which in turn drives pituitary LH and FSH and therefore testicular/ovarian sex-hormone output. Because it acts upstream and physiologically, it produces a natural hormonal cascade and is studied as a more physiological alternative to direct gonadotropin stimulation.
Potential Benefits & Side Effects
- Stimulated endogenous GnRH → LH/FSH → sex hormones
- Physiological, upstream HPG-axis activation
- Studied for fertility and hypogonadism
- Short-acting, pulsatile-friendly profile
- Injection-site reactions
- Short half-life (frequent dosing needed)
- Desensitisation risk with continuous high dosing
- Limited long-term data
Lifestyle Factors
- Adequate hydration and 7–9 h of sleep are standard controls in most research protocols.
- Consistent dose timing improves the reliability of any self-tracked endpoints.
- Maintain a clean, sterile workflow for every draw to avoid contamination.
Injection Technique
- 1Wash hands, then prep the vial top and the target site with separate alcohol swabs.
- 2Pinch a subcutaneous skin fold (abdomen, ~2 inches from the navel) and insert at 45–90°.
- 3Depress the plunger slowly over 3–5 seconds, hold 5 seconds, then withdraw.
- 4Rotate sites each administration and dispose of the syringe in a sharps container.
Frequently Asked Questions
CG Labz Verified Batches
No published batches yet.
Research Disclaimer
All compounds are supplied strictly for laboratory research. Dosing figures below summarize ranges reported in published preclinical and clinical literature for reference purposes only. CG Labz does not provide medical advice or individualized dosing recommendations.
References
- [1] Journal of Clinical InvestigationDhillo W.S. et al. Kisspeptin-54 stimulates the HPG axis in humans.View Source